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An Atypical Presentation of Tissue Invasive CMV in an
Immunocompromised Patient
Krishna Modi MD; Ali Omari; Odaliz Abreu-Lanfranco MD
Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan
Abstract
• Patients with HIV AIDS are at increased risk for opportunistic infections, and
require prompt treatment.
• We present a case of a young male with HIV AIDS, CD4 < 50 cells/microL who
had a febrile syndrome, encephalopathy in the setting of a largely negative
infectious evaluation.
• Cerebrospinal fluid had negative virology, and MRI brain showed generalized
cortical atrophy concerning for HIV encephalopathy.
• The patient also had a coccygeal ulcer that did not have purulence to it, but was
found to be CMV positive. This prompted further evaluation of tissue invasive
CMV diseases. He was found to be viremic, and also have retinitis.
• The patient had resolution of his fevers, and rapid improvement of his mental
status when started on ganciclovir therapy. He was soon started on anti-retroviral
therapy targeted at his HIV.
• This case demonstrates tissue invasive CMV causing a febrile syndrome,
dermatologic manifestation, retinitis, and encephalopathy.
• CMV infection needs to be suspected in immunocompromised patients with
ulcerations, and vesicles as it may be the only initial indication of tissue invasive
CMV disease.

• Further infectious evaluation includes a negative urinalysis, blood cultures, ß-D
Glucan assay, galactomannan, and cerebrospinal fluid studies that include testing
for bacteria, fungi, and viruses.
• Brain CT and MRI showed no masses or bleeding, but did show chronic changes of
cortical atrophying with ex vacuo ventricular dilatation.
• Viral swab studies of the coccygeal ulcer returned from an outside lab are positive
for CMV, herpes simplex virus (HSV)-1, and HSV-2. Ophthalmology performs a
dilated eye exam that is significant for a band of left eye retinitis without macular
involvement. CMV levels in the blood are 1,536 IU/mL.
• The patient was started on intravenous ganciclovir which resulted in resolution of
his fevers and rapid improvement in mentation back to baseline. The patient
confirmed pain related to his coccygeal ulcer, but reported no headaches, vision
changes, trouble swallowing, or diarrhea.
• As the patient was asymptomatic, and did not have macular involvement in the
ophthalmic exam, intra-vitreous ganciclovir was deferred.
• After two weeks of intra-venous ganciclovir, the patient was transitioned to oral
valganciclovir, was started on ART, and was able to be discharged.

Images

Introduction
• In the era of anti-retroviral therapy (ART), patients with HIV have improved
mortality and morbidity, with less opportunistic infections.
• Patients with HIV infections are typically asymptomatic until they become severely
immunocompromised, with AIDS being defined with a cell count of less than
200cells/microL or with an AIDS defining illness.
• HIV can manifest with lesions of the skin and mucous membranes, including
candida infections, oral hairy leukoplakia, and seborrheic dermatitis.
• As patients become more immunosuppressed, viral infections become more
prevalent, including with herpes simplex viruses (HSV), varicella zoster (VZV), and
human papillomaviruses (HPV).
• Cytomegalovirus (CMV) is a common infection that results in lifelong latent
infection. This refers to a positive CMV PCR test, and does not necessarily result in
active symptoms.
• When patients are immunocompromised, it can cause a broad range of tissue
invasive diseases. These can present as febrile syndromes, hepatitis, pneumonitis,
retinitis, encephalitis, esophagitis, and/or colitis.

• We present a case of tissue invasive CMV presenting with cutaneous eruption,
retinitis, and causing encephalopathy in an AIDS patient.
• This patient was admitted with altered mental status, and was found to have a
pneumonia. He competed treatment, however continued to spike fevers, and
continued to be encephalopathic. There was concern that his fevers and
encephalopathy could be secondary to HIV, and whether ART could be initiated.
• CSF viral studies were negative, and MRI brain imaging was concerning for HIV
encephalopathy. CMV blood titers are not typically attained as viremia is not an
indication for tissue invasive disease.
• The patient had rapid improvement of his fevers, and mental status improved
rapidly upon initiation of ganciclovir therapy.
• CMV typically does not present with cutaneous eruptions, though it has been
reported in anogenital ulcerations in non-AIDS patients as being a co-infection
with HSV. 1
• Other reports of CMV cutaneous infection include vesicles similar to that of
varicella zoster virus, but without improvement on acyclovir. 2 It can also present
with papulopustules, and vesiculobullous eruptions. 3
• Cutaneous CMV lesions are rare, but is associated with increased mortality of
85% in 6 months in transplant patients. 4
• Encephalopathic AIDS patients get routine MRI brain to rule out toxoplasmosis,
and lymphoma. In setting of CMV, there may be peri-ventricular enhancement,
but this is not a sensitive or specific finding. 5 CMV neurologic disease is
diagnosed with a positive CSF PCR study with high sensitivity and specificity. 6
• This is a case of tissue invasive CMV with dermatologic and ophthalmic disease
causing fevers and infection related encephalopathy.

Conclusions

Figure 1. Stage 3 coccygeal ulcer, CMV positive.

• Patients with AIDS are severely immunocompromised, and need a comprehensive
infectious evaluation to rule out atypical infectious presentations.
• CMV needs to be suspected in both AIDS and transplant recipient patients as a
possible cause for febrile syndromes.
• CMV can cause dermatologic manifestation with ulcerations which can be coinfected with HSV. These have been seen previously in the anogenital regions.
• Tissue invasive CMV can be the underlying cause of encephalopathy without
meningitis or encephalitis.
• Ganciclovir therapy results in rapid response in tissue invasive CMV.
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